Alliance Brings More Firepower to the Fight Against Cancer

December 1, 2016 | City of Hope

City of Hope joins forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and clinicians can convert research discoveries into cures.

Continue Reading

Study: Stem Cell Transplants May Lead to Cure for Some T1D Patients

March 7, 2017 | Letisia Marquez

Clinical trial shows promising results from risky procedure, identifies path for personalized therapies. The results were published recently in the journal, Frontiers in Immunology.

Researchers achieve remission using CAR-T Cell therapy for aggressive brain tumors

February 15, 2017 | Denise Heady

City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR-T cells dramatically improved quality of life for patient with recurrent glioblastoma.

City of Hope Hosts Visiting Chinese Physicians

February 3, 2017 | Michael Easterling

As part of its Center for International Medicine (CIM) program, City of Hope recently hosted seven physicians from Renmin Hospital of Wuhan University, located the Hubei province of China.

Researchers tackle two difficult-to-treat lymphomas

February 2, 2017 | Letisia Marquez

New study in the Journal of Clinical Oncology concludes that patients with relapsed or treatment-resistant double-hit and/or double-expressor lymphomas didn’t respond as well to the transplantation as diffuse large B-cell lymphoma patients who did not have those types of lymphoma.

New Goal for Type 1 Diabetes Cure

January 16, 2017 | Letisia Marquez

A cure for Type 1 diabetes (T1D) in six years is the new goal of City of Hope’s Diabetes and Metabolism Research Institute. With more than $50 million in private funding, the institute will be able to lead an innovative research effort that seeks to find a cure for T1D.

Hodgkin Lymphoma Trial Results Promising

January 9, 2017 | Abe Rosenberg

Everything changed when a Hodgkin lymphoma patient joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.

Steven T. Rosen, M.D. on the Latest Breakthroughs in Blood Cancer Treatment

December 16, 2016 | City of Hope

The long-term strategies offered by City of Hope’s Hematologic Malignancies (HM) Program have dramatically improved the lives of patients with leukemia, lymphoma, Hodgkin’s disease and multiple myeloma.

Cutaneous Lymphoma Clinical Trials

December 16, 2016 | City of Hope

While treatment therapies exist for CTCL (MF/SS) and other cutaneous lymphomas, the most prevalent therapies have not yet offered consistent and sustained response or cure. Our multidisciplinary team continues to provide leadership in research and in developing therapies to advance a cure.

Using CAR-T cell immunotherapy to target glioblastomas

December 14, 2016 | Denise Heady

One of but a few centers in the United States offering human studies in CAR–T cell therapy, City of Hope is the only center investigating CAR-T cells in injection form administered directly to brain tumors.

Load More